Sabra Health Care REIT, Inc. (SBRA)
Every FINRA and SEC series the site collects for Sabra Health Care REIT, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as real estate investment trusts.
24.7M
Short interest
settlement 2026-08-14
8.7
Days to cover
+0.6% vs prior
57.8%
Short share of volume
2026-09-11
1,830
Fails to deliver
settlement 2026-08-11
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in SBRA is 24,694,549 shares, down 292,702 shares over the last month. Over the last 48 readings it ranged from 15,479,553 shares (30 September 2025) to 31,368,412 shares (15 May 2026). At the reported average volume of 2.8M shares a day that is 8.7 days to cover, elevated.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/sbra" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 24,694,549 | +0.6% | 2,828,568 | 8.73 |
| 2026-07-31 | 24,536,972 | -1.8% | 3,313,066 | 7.41 |
| 2026-07-15 | 24,987,251 | -5.3% | 2,639,926 | 9.47 |
| 2026-06-30 | 26,378,910 | -0.6% | 4,304,947 | 6.13 |
| 2026-06-15 | 26,545,381 | -9.6% | 3,345,318 | 7.94 |
| 2026-05-29 | 29,354,405 | -6.4% | 2,245,558 | 13.07 |
| 2026-05-15 | 31,368,412 | +8.2% | 1,896,284 | 16.54 |
| 2026-04-30 | 28,986,868 | +4.3% | 2,548,019 | 11.38 |
| 2026-04-15 | 27,782,016 | +0.2% | 1,502,330 | 18.49 |
| 2026-03-31 | 27,734,062 | +5.0% | 2,642,489 | 10.50 |
| 2026-03-13 | 26,425,907 | +6.3% | 2,343,042 | 11.28 |
| 2026-02-27 | 24,868,626 | +7.6% | 2,905,994 | 8.56 |
| 2026-02-13 | 23,116,308 | +4.3% | 3,361,502 | 6.88 |
| 2026-01-30 | 22,170,471 | -2.6% | 2,692,532 | 8.23 |
| 2026-01-15 | 22,770,341 | +0.3% | 2,494,256 | 9.13 |
| 2025-12-31 | 22,710,045 | -10.5% | 2,208,936 | 10.28 |
| 2025-12-15 | 25,386,215 | +7.3% | 3,252,641 | 7.80 |
| 2025-11-28 | 23,647,917 | +21.5% | 2,700,777 | 8.76 |
| 2025-11-14 | 19,467,130 | +3.1% | 3,769,105 | 5.16 |
| 2025-10-31 | 18,879,043 | -0.4% | 2,316,651 | 8.15 |
| 2025-10-15 | 18,954,578 | +22.4% | 3,713,519 | 5.10 |
| 2025-09-30 | 15,479,553 | -21.2% | 2,211,626 | 7.00 |
| 2025-09-15 | 19,648,320 | +1.6% | 1,933,594 | 10.16 |
| 2025-08-29 | 19,338,122 | +7.0% | 2,421,647 | 7.99 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of SBRA volume is 57.8%, down 12.8 points over the last five sessions. Over the last 52 readings it ranged from 34.3% (20 July 2026) to 82.6% (4 September 2026). The latest reading is 2.1 points above the 30-session average of 55.8%, on 702K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 406K | 702K | 57.8% | 434 |
| 2026-09-10 | 443K | 875K | 50.6% | 0 |
| 2026-09-09 | 598K | 867K | 68.9% | 33 |
| 2026-09-08 | 453K | 709K | 63.9% | 695 |
| 2026-09-04 | 480K | 581K | 82.6% | 0 |
| 2026-09-03 | 398K | 563K | 70.7% | 0 |
| 2026-09-02 | 409K | 706K | 58.0% | 0 |
| 2026-09-01 | 564K | 841K | 67.0% | 3,446 |
| 2026-08-31 | 228K | 523K | 43.5% | 612 |
| 2026-08-28 | 421K | 568K | 74.0% | 0 |
| 2026-08-27 | 204K | 341K | 59.9% | 2,300 |
| 2026-08-26 | 391K | 603K | 64.8% | 50 |
| 2026-08-25 | 290K | 503K | 57.6% | 1,132 |
| 2026-08-24 | 127K | 304K | 41.8% | 0 |
| 2026-08-21 | 126K | 300K | 41.9% | 5 |
| 2026-08-20 | 184K | 380K | 48.4% | 0 |
| 2026-08-19 | 193K | 422K | 45.7% | 32 |
| 2026-08-18 | 166K | 348K | 47.6% | 0 |
| 2026-08-17 | 183K | 414K | 44.2% | 97 |
| 2026-08-14 | 342K | 774K | 44.2% | 266 |
| 2026-08-13 | 419K | 658K | 63.6% | 55 |
| 2026-08-12 | 314K | 917K | 34.3% | 191 |
| 2026-08-11 | 559K | 1.1M | 50.5% | 2 |
| 2026-08-10 | 504K | 736K | 68.4% | 53 |
| 2026-08-07 | 239K | 457K | 52.3% | 1,363 |
| 2026-08-06 | 244K | 546K | 44.6% | 95 |
| 2026-08-05 | 507K | 928K | 54.7% | 1,167 |
| 2026-08-04 | 927K | 1.8M | 52.9% | 0 |
| 2026-08-03 | 827K | 1.3M | 62.1% | 0 |
| 2026-07-31 | 407K | 723K | 56.3% | 908 |
Fails to deliver
SEC, by settlement date. JSONAs of 11 August 2026, the fails-to-deliver balance in SBRA is 1,830 shares, up 1,651 shares over the last settlement date. Over the last 52 readings it ranged from 8 shares (29 June 2026) to 232,243 shares (12 March 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-11 | 1,830 | $20.67 | $38K |
| 2026-07-16 | 179 | $19.52 | $3K |
| 2026-07-01 | 3,273 | $19.51 | $64K |
| 2026-06-29 | 8 | $19.54 | $156 |
| 2026-06-24 | 24,244 | $18.63 | $452K |
| 2026-06-23 | 13,764 | $18.27 | $251K |
| 2026-06-22 | 11,811 | $18.12 | $214K |
| 2026-06-17 | 19,492 | $18.56 | $362K |
| 2026-06-15 | 4,904 | $18.73 | $92K |
| 2026-06-12 | 17,533 | $18.49 | $324K |
| 2026-06-11 | 63,240 | $18.82 | $1.2M |
| 2026-06-10 | 255 | $18.90 | $5K |
| 2026-06-05 | 912 | $17.67 | $16K |
| 2026-06-04 | 25,708 | $18.09 | $465K |
| 2026-04-29 | 2,874 | $20.51 | $59K |
| 2026-04-24 | 49 | $19.91 | $976 |
| 2026-04-20 | 6,000 | $20.68 | $124K |
| 2026-04-10 | 90 | $20.35 | $2K |
| 2026-04-09 | 342 | $20.08 | $7K |
| 2026-04-08 | 157 | $20.01 | $3K |
| 2026-04-07 | 190 | $19.72 | $4K |
| 2026-03-31 | 32,769 | $19.44 | $637K |
| 2026-03-25 | 11,480 | $19.73 | $227K |
| 2026-03-23 | 9,913 | $19.59 | $194K |
| 2026-03-12 | 232,243 | $20.65 | $4.8M |
| 2026-02-26 | 4,800 | $20.56 | $99K |
| 2026-02-23 | 291 | $19.93 | $6K |
| 2026-02-11 | 849 | $19.15 | $16K |
| 2026-02-09 | 33 | $19.03 | $628 |
| 2026-02-06 | 34,720 | $19.18 | $666K |
Insider trades
SEC Form 4, newest first, 50 of 85 shown. JSONNo open-market insider trades were reported for SBRA in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Smith Darrin (Executive VP, CIO & Secretary) on 2026-08-31.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Smith Darrin | Executive VP, CIO & Secretary | Grant | 495 | $0.00 | $0 | 117K |
| 2026-08-31 | Malehorn Jeffrey A. | n/a | Grant | 791 | $0.00 | $0 | 117K |
| 2026-08-31 | MATROS RICHARD K | Chair, CEO and President | Grant | 14K | $0.00 | $0 | 956K |
| 2026-08-31 | Kono Ann | n/a | Grant | 791 | $0.00 | $0 | 69K |
| 2026-08-31 | KATZMANN LYNNE S | n/a | Grant | 791 | $0.00 | $0 | 87K |
| 2026-08-31 | FOSTER MICHAEL J | n/a | Grant | 791 | $0.00 | $0 | 83K |
| 2026-08-31 | FLORES JESSICA | Executive VP & CAO | Grant | 382 | $0.00 | $0 | 72K |
| 2026-08-31 | Cusack Catherine | n/a | Grant | 791 | $0.00 | $0 | 83K |
| 2026-08-31 | Costa Michael Lourenco | Executive VP, CFO & Treasurer | Grant | 4K | $0.00 | $0 | 470K |
| 2026-08-31 | Barbarosh Craig A. | n/a | Grant | 791 | $0.00 | $0 | 55K |
| 2026-06-17 | Barbarosh Craig A. | n/a | Grant | 8K | $0.00 | $0 | 63K |
| 2026-05-29 | Smith Darrin | Executive VP, CIO & Secretary | Grant | 501 | $0.00 | $0 | 116K |
| 2026-05-29 | Malehorn Jeffrey A. | n/a | Grant | 817 | $0.00 | $0 | 108K |
| 2026-05-29 | MATROS RICHARD K | Chair, CEO and President | Grant | 14K | $0.00 | $0 | 942K |
| 2026-05-29 | Kono Ann | n/a | Grant | 817 | $0.00 | $0 | 60K |
| 2026-05-29 | KATZMANN LYNNE S | n/a | Grant | 817 | $0.00 | $0 | 78K |
| 2026-05-29 | FOSTER MICHAEL J | n/a | Gift | 500 | $0.00 | $0 | 74K |
| 2026-05-29 | FOSTER MICHAEL J | n/a | Grant | 817 | $0.00 | $0 | 74K |
| 2026-05-29 | FLORES JESSICA | Executive VP & CAO | Grant | 385 | $0.00 | $0 | 72K |
| 2026-05-29 | Cusack Catherine | n/a | Grant | 817 | $0.00 | $0 | 74K |
| 2026-05-29 | Costa Michael Lourenco | Executive VP, CFO & Treasurer | Grant | 4K | $0.00 | $0 | 466K |
| 2026-05-29 | Barbarosh Craig A. | n/a | Grant | 817 | $0.00 | $0 | 55K |
| 2026-05-27 | FOSTER MICHAEL J | n/a | Gift | 490 | $0.00 | $0 | 73K |
| 2026-05-22 | FOSTER MICHAEL J | n/a | Gift | 813 | $0.00 | $0 | 74K |
| 2026-03-25 | FLORES JESSICA | Executive VP & CAO | Sell | 15K | $19.86 | $302K | 72K |
| 2026-02-27 | Smith Darrin | Executive VP, CIO & Secretary | Grant | 478 | $0.00 | $0 | 116K |
| 2026-02-27 | Malehorn Jeffrey A. | n/a | Grant | 781 | $0.00 | $0 | 107K |
| 2026-02-27 | MATROS RICHARD K | Chair, CEO and President | Grant | 13K | $0.00 | $0 | 928K |
| 2026-02-27 | Kono Ann | n/a | Grant | 781 | $0.00 | $0 | 59K |
| 2026-02-27 | KATZMANN LYNNE S | n/a | Grant | 781 | $0.00 | $0 | 77K |
| 2026-02-27 | FOSTER MICHAEL J | n/a | Grant | 781 | $0.00 | $0 | 75K |
| 2026-02-27 | FLORES JESSICA | Executive VP & CAO | Grant | 368 | $0.00 | $0 | 87K |
| 2026-02-27 | Cusack Catherine | n/a | Grant | 781 | $0.00 | $0 | 73K |
| 2026-02-27 | Costa Michael Lourenco | Executive VP, CFO & Treasurer | Grant | 4K | $0.00 | $0 | 462K |
| 2026-02-27 | Barbarosh Craig A. | n/a | Grant | 781 | $0.00 | $0 | 54K |
| 2026-02-10 | Smith Darrin | Executive VP, CIO & Secretary | Tax withholding | 6K | $19.15 | $122K | 115K |
| 2026-02-10 | Smith Darrin | Executive VP, CIO & Secretary | Grant | 14K | $0.00 | $0 | 122K |
| 2026-02-10 | Smith Darrin | Executive VP, CIO & Secretary | Tax withholding | 3K | $19.15 | $56K | 108K |
| 2026-02-10 | Smith Darrin | Executive VP, CIO & Secretary | Grant | 5K | $0.00 | $0 | 111K |
| 2026-02-10 | MATROS RICHARD K | Chair, CEO and President | Grant | 85K | $0.00 | $0 | 915K |
| 2026-02-10 | FLORES JESSICA | Executive VP & CAO | Tax withholding | 1K | $19.15 | $22K | 87K |
| 2026-02-10 | FLORES JESSICA | Executive VP & CAO | Grant | 3K | $0.00 | $0 | 88K |
| 2026-02-10 | Costa Michael Lourenco | Executive VP, CFO & Treasurer | Grant | 23K | $0.00 | $0 | 458K |
| 2026-01-08 | Smith Darrin | Executive VP, CIO & Secretary | Tax withholding | 5K | $19.61 | $97K | 105K |
| 2026-01-08 | Smith Darrin | Executive VP, CIO & Secretary | Tax withholding | 5K | $19.61 | $107K | 110K |
| 2026-01-08 | Smith Darrin | Executive VP, CIO & Secretary | Grant | 14K | $0.00 | $0 | 116K |
| 2026-01-08 | MATROS RICHARD K | Chair, CEO and President | Gift | 233K | $0.00 | $0 | 830K |
| 2026-01-08 | MATROS RICHARD K | Chair, CEO and President | Tax withholding | 224K | $19.61 | $4.4M | 1.1M |
| 2026-01-08 | MATROS RICHARD K | Chair, CEO and President | Grant | 319K | $0.00 | $0 | 1.3M |
| 2026-01-08 | FLORES JESSICA | Executive VP & CAO | Tax withholding | 4K | $19.61 | $77K | 85K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
13F holders
Tracked managers holding SBRA at their latest 13F. JSON6 of the 30 tracked managers held SBRA at their latest 13F, $141.2M in total at quarter-end prices. AQR Capital Management is the largest at $39.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 2.0M | $39.0M | 0.01% | +585K |
| Two Sigma Investments | 2026-06-30 | 1.9M | $38.0M | 0.03% | -561K |
| Point72 Asset Management | 2026-06-30 | 1.1M | $21.8M | 0.02% | +555K |
| D. E. Shaw & Co. | 2026-06-30 | 834K | $16.3M | 0.01% | -198K |
| Millennium Management | 2026-06-30 | 746K | $14.6M | 0.01% | -839K |
| Citadel Advisors | 2026-06-30 | 596K | $11.6M | 0.00% | -108K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Sabra Health Care REIT, Inc. reported revenue of $128.8M, up 63.1% from the same quarter a year earlier, and net loss of $25.2M (-0.10 diluted EPS). In FY 2025 it generated $348.6M of operating cash flow and spent $289.5M on dividends. As of 2026-06-30, cash was $231.6M against $2.63B of debt.
- Cash
- $231.6M
- Debt
- $2.63B
- Equity
- $2.75B
- Total assets
- $5.51B
- Shares outstanding
- 255,462,756
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $128.8M | -$25.2M | -19.6% | -0.10 |
| Q1 2026 | 2026-03-31 | $116.7M | $40.9M | 35.0% | 0.16 |
| Q4 2025derived | 2025-12-31 | $108.4M | $27.2M | 25.1% | n/a |
| Q3 2025 | 2025-09-30 | $92.0M | $22.5M | 24.5% | 0.09 |
| Q2 2025 | 2025-06-30 | $79.0M | $65.5M | 83.0% | 0.27 |
| Q1 2025 | 2025-03-31 | $77.4M | $40.3M | 52.0% | 0.17 |
| Q4 2024derived | 2024-12-31 | $76.9M | $46.7M | 60.7% | n/a |
| Q3 2024 | 2024-09-30 | $73.7M | $29.8M | 40.4% | 0.13 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $356.9M | $155.6M | $348.6M | n/a | n/a | $289.5M |
| FY 2024 | 2024-12-31 | $284.6M | $126.7M | $310.5M | n/a | n/a | $280.1M |
| FY 2023 | 2023-12-31 | $236.2M | $13.8M | $300.6M | n/a | n/a | $277.4M |
| FY 2022 | 2022-12-31 | $186.7M | -$77.6M | $315.7M | n/a | n/a | $277.2M |
| FY 2021 | 2021-12-31 | $155.5M | -$113.3M | $356.4M | n/a | n/a | $262.9M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-27 from the cover page.
What this page is
Sabra Health Care REIT, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Sabra Health Care REIT, Inc. (SBRA), SEC CIK 1492298, listed on Nasdaq, classified by the SEC as real estate investment trusts. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-11.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-31.JSON and CSV
- Company record
- EDGAR filing index for CIK 1492298Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as real estate investment trusts
- EQIXEQUINIX INC
- AREALEXANDRIA REAL ESTATE EQUITIES, INC.
- VTRVentas, Inc.
- IRMIRON MOUNTAIN INC
- ACRACRES Commercial Realty Corp.
- ARRArmour Residential REIT, Inc.
- BFSSAUL CENTERS, INC.
- CBLCBL & ASSOCIATES PROPERTIES INC
- SBACSBA COMMUNICATIONS CORP
- NYCAmerican Strategic Investment Co.
- MKZRMacKenzie Realty Capital, Inc.
- UMHUMH PROPERTIES, INC.
- ELSEQUITY LIFESTYLE PROPERTIES INC
- PMTPennyMac Mortgage Investment Trust
- NHINATIONAL HEALTH INVESTORS INC
- AMHAmerican Homes 4 Rent
- OREALTY INCOME CORP
- EPREPR PROPERTIES
- APLEApple Hospitality REIT, Inc.
- PMTUPennyMac Mortgage Investment Trust
- PMTVPennyMac Mortgage Investment Trust
- PMTWPennyMac Mortgage Investment Trust
- CRWVCoreWeave, Inc.
- UTHRUNITED THERAPEUTICS Corp
Datasets
Frequently Asked Questions
How much of SBRA is sold short?
What is SBRA's daily short volume?
Does SBRA have fails to deliver?
Are SBRA insiders buying or selling?
What did SBRA report last quarter?
Which funds hold SBRA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.